Literature DB >> 5573439

An assessment of platelet aggregation induced by 5-hydroxytryptamine.

B P Hilton, J N Cumings.   

Abstract

A method of expressing platelet aggregation response after incubation relative to the response before incubation has been used in preference to using direct measurements, and some reasons are given for this choice. The effect of pre-incubating human platelets with reserpine has been compared with the effect of pre-incubation with 5-hydroxytryptamine (5HT). Reserpine inhibited 5HT-induced aggregation more slowly than 5HT and on this basis their actions could be distinguished. It was found that the aggregation response of human platelets to 5HT without pre-incubation (R) is inversely proportional to the natural 5HT content of whole blood, and an explanation has been suggested.A decrease in the aggregation response of human platelets to 5HT without pre-incubation (R) with increasing age has been noted, and is commented upon with reference to the release of amines from blood platelets. Platelets in plasma obtained from control subjects and incubated with methysergide and from migrainous patients taking methysergide both have reduced aggregation responses to 5HT. Platelets incubated with clonidine (St155) do not have reduced aggregation responses. A potentiating effect was noted after 20 minutes' incubation, but platelets from migraine patients taking St155 behaved normally. Tyramine affected the response of platelets to 5HT, giving results similar to those reported for reserpine. The differences between the aggregation responses to 5HT of platelets from migraine patients and normal control subjects are discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5573439      PMCID: PMC476964          DOI: 10.1136/jcp.24.3.250

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  ESTIMATION OF 5-HYDROXYTRYPTAMINE IN HUMAN BLOOD.

Authors:  G W ASHCROFT; T B CRAWFORD; J K BINNS; E J MACDOUGALL
Journal:  Clin Chim Acta       Date:  1964-04       Impact factor: 3.786

2.  METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS.

Authors:  J R GRAHAM
Journal:  N Engl J Med       Date:  1964-01-09       Impact factor: 91.245

3.  DECOMPOSITION OF DILUTE HYDROGEN PEROXIDE IN ALKALINE SOLUTIONS.

Authors:  G BARTHOLINI; A PLETSCHER; H BRUDERER
Journal:  Nature       Date:  1964-09-19       Impact factor: 49.962

4.  A possible pharmacological approach to migraine.

Authors:  E Zaimis; E Hanington
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

5.  Clonidine for migraine.

Authors:  M Wilkinson
Journal:  Lancet       Date:  1969-08-23       Impact factor: 79.321

Review 6.  Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets.

Authors:  A Pletscher
Journal:  Br J Pharmacol Chemother       Date:  1968-01

7.  Effects of 5-hydroxytryptamine on platelet aggregation.

Authors:  H R Baumgartner; G V Born
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

8.  Relationship between chemical structure and platelet-aggregation activity of prostaglandins.

Authors:  J Kloeze
Journal:  Biochim Biophys Acta       Date:  1969-10-28

9.  Comparative trial of serotonin antagonists in the management of migraine.

Authors:  J W Lance; M Anthony; B Somerville
Journal:  Br Med J       Date:  1970-05-09

10.  Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects.

Authors:  D A Curran; H Hinterberger; J W Lance
Journal:  Brain       Date:  1965-12       Impact factor: 13.501

View more
  10 in total

1.  Effects of reserpine and chlorpromazine on 5-hydroxytryptamine uptake of platelets from migrainous and control subjects.

Authors:  B P Hilton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-06       Impact factor: 10.154

2.  Prophylaxis of migraine.

Authors:  M H Kronby
Journal:  Can Fam Physician       Date:  1980-07       Impact factor: 3.275

3.  Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study.

Authors:  Daniela Trabattoni; Marta Brambilla; Paola Canzano; Alessia Becchetti; Giovanni Teruzzi; Benedetta Porro; Susanna Fiorelli; Manuela Muratori; Calogero C Tedesco; Fabrizio Veglia; Piero Montorsi; Antonio L Bartorelli; Elena Tremoli; Marina Camera
Journal:  JACC Basic Transl Sci       Date:  2022-04-13

4.  Effects of ergotamine and methysergide on blood platelet aggregation responses of migrainous subjects.

Authors:  B P Hilton; K J Zilkha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-05       Impact factor: 10.154

5.  Decreased platelet 3H-imipramine binding sites in classical migraine.

Authors:  D P Geaney; M G Rutterford; J M Elliott; M Schächter; K M Peet; D G Grahame-Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

6.  Measurement of activity of 5-HT antagonists following oral administration in man: a comparison of methysergide and BW501.

Authors:  J O'Grady; E Peringer; G John
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

7.  5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache.

Authors:  B P Hilton; J N Cumings
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-08       Impact factor: 10.154

8.  The effect of an antiserotonin agent pizotifen on platelet aggregability in migraine patients.

Authors:  S Mazal; E A Rachmilewitz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-12       Impact factor: 10.154

9.  Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans.

Authors:  Ana Marin D Carneiro; Edwin H Cook; Dennis L Murphy; Randy D Blakely
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

10.  Effects of methysergide on platelets incubated with reserpine.

Authors:  J N Cumings; B P Hilton
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.